FDAClass IIIApril 10, 2013

Tizanidine Tablets USP recall: Labeling Error

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC…

Why was Tizanidine Tablets USP recalled?

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.

Product
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC…
Recalling firm
Dr. Reddy'S Laboratories
Quantity
117,546 bottles
Distribution
Nationwide and Puerto Rico.
Recall date
April 10, 2013
Classification
Class III
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls